To hear about similar clinical trials, please enter your email below
Trial Title:
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study
NCT ID:
NCT06064149
Condition:
Prostate Cancer
Conditions: Official terms:
Prostatic Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
CARE-PC Web-Based Application
Description:
The CARE-PC app is a pragmatic, patient-oriented, web-based application that enables the
education of patients regarding cardiovascular (CV) risks and collects CV and prostate
cancer-related risk variables and CV care access data from prostate cancer patients
receiving ADT.
Arm group label:
Men With Prostate Cancer Planned for Receiving ADT
Summary:
The overarching goal of this trial is to develop mechanisms to improve cardiovascular
care among such prostate cancer patients receiving ADT by increasing patient awareness of
individualized cardiovascular risk estimates and mitigation opportunities. Patients will
be given access to a web-based quality improvement tool to educate patients of
cardiovascular risks in prostate cancer and to inform them of their individualized,
estimated cardiovascular risk and guideline-based risk mitigation recommendations.
The study will assess the feasibility of this web-based application as a cardiovascular
education tool for patients with prostate cancer.
The study will also evaluate if completion of the web-based tool improves cardiovascular
care access and risk mitigation for patients with prostate cancer.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Men with prostate cancer > 18 years of age who are currently receiving or will be
receiving treatment with ≥ 6 months of ADT
- Patients must be able to read and understand English.
Exclusion Criteria: n/a
Gender:
Male
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Abramson Cancer Center of the University of Pennsylvania
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Vivek Narayan, MD
Phone:
215-360-0737
Email:
PennCancerTrials@emergingmed.com
Start date:
November 14, 2023
Completion date:
June 30, 2026
Lead sponsor:
Agency:
Vivek Narayan
Agency class:
Other
Collaborator:
Agency:
National Comprehensive Cancer Network
Agency class:
Other
Source:
Abramson Cancer Center at Penn Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06064149
